Literature DB >> 5132580

Effects of L-DOPA treatment on indole metabolism in Parkinson's disease.

G G Brune, K W Pflughaupt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5132580     DOI: 10.1007/BF02147571

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  5 in total

1.  Identification and assay of urinary tryptamine: application as an index of monoamine oxidase inhibition in man.

Authors:  A SJOERDSMA; J A OATES; P ZALTZMAN; S UDENFRIEND
Journal:  J Pharmacol Exp Ther       Date:  1959-07       Impact factor: 4.030

2.  Formation of indole-3-acetic acid and tryptamine in animals: a method for estimation of indole-3-acetic acid in tissues.

Authors:  H WEISSBACH; W KING; A SJOERDSMA; S UDENFRIEND
Journal:  J Biol Chem       Date:  1959-01       Impact factor: 5.157

3.  The identification of 5-hydroxy-3-indoleacetic acid in normal urine and a method for its assay.

Authors:  S UDENFRIEND; E TITUS; H WEISSBACH
Journal:  J Biol Chem       Date:  1955-10       Impact factor: 5.157

4.  L-dopa: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice.

Authors:  G M Everett; J W Borcherding
Journal:  Science       Date:  1970-05-15       Impact factor: 47.728

5.  Aromatic amino acids and modification of parkinsonism.

Authors:  G C Cotzias; M H Van Woert; L M Schiffer
Journal:  N Engl J Med       Date:  1967-02-16       Impact factor: 91.245

  5 in total
  3 in total

Review 1.  [Modern treatment of parkinsonism].

Authors:  W Birkmayer; E Neumayer
Journal:  Z Neurol       Date:  1972

2.  Proceedings: Effect of amantadine on the urinary excretion of some monoamines and metabolites in normal and parkinsonian subjects.

Authors:  D G Jones; J A Lenman; M A Robertson; M J Turnbull
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

Review 3.  Tryptamine: a metabolite of tryptophan implicated in various neuropsychiatric disorders.

Authors:  D D Mousseau
Journal:  Metab Brain Dis       Date:  1993-03       Impact factor: 3.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.